CRP and Alzheimer disease: They reported that the APOE ε4 allele coupled with chronic low-grade inflammation, defined as a CRP level of 8mg/L or higher, was associated with an increased risk of AD as well as an increased risk of earlier disease onset compared with APOE ε4 carriers without chronic inflammation [23].